Morphine Sulfate Patent Expiration
Morphine Sulfate was first introduced by Hikma Pharmaceuticals Usa Inc
Morphine Sulfate Patents
Given below is the list of patents protecting Morphine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Morphine Sulfate | US9072781 | Morphine formulations | Mar 12, 2034 | Fresenius Kabi Usa |
| Morphine Sulfate | US9192608 | Morphine formulations | Mar 12, 2034 | Fresenius Kabi Usa |
| Morphine Sulfate | US9248229 | Packaging system for oxygen-sensitive drugs | Mar 12, 2034 | Fresenius Kabi Usa |
| Arymo Er | US9044402 | Abuse-deterrent pharmaceutical compositions for controlled release | Jul 01, 2033 | Zyla |
| Arymo Er | US9549899 | Abuse deterrent pharmaceutical compositions for controlled release | Jul 01, 2033 | Zyla |
| Morphabond Er | US10314788 | Pharmaceutical compositions configured to deter dosage form splitting | Aug 12, 2028 | Ohemo Life |
| Morphabond Er | US7955619 | Abuse resistant drugs, method of use and method of making | Aug 12, 2028 | Ohemo Life |
| Avinza | US6066339 | Oral morphine multiparticulate formulation |
Nov 25, 2017
(Expired) | King Pharms Llc |
| Depodur | US5891467 | Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
Jan 31, 2017
(Expired) | Pacira Pharms Inc |
| Depodur | US5962016 | Multivesicular liposomes utilizing neutral lipids to modify in vivo release |
Jan 31, 2017
(Expired) | Pacira Pharms Inc |
| Depodur | US6171613 | Method for producing liposomes with increased percent of compound encapsulated |
Oct 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US5997899 | Method for producing liposomes with increased percent of compound encapsulated |
Sep 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US6193998 | Method for producing liposomes with increased percent of compound encapsulated |
Sep 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US6241999 | Method for producing liposomes with increased percent of compound encapsulated |
Sep 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US5807572 | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Sep 15, 2015
(Expired) | Pacira Pharms Inc |
| Depodur | US5931809 | Epidural administration of therapeutic compounds with sustained rate of release |
Jul 14, 2015
(Expired) | Pacira Pharms Inc |
| Depodur | US5723147 | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Mar 03, 2015
(Expired) | Pacira Pharms Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Morphine Sulfate's patents.
Latest Legal Activities on Morphine Sulfate's Patents
Given below is the list recent legal activities going on the following patents of Morphine Sulfate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Aug, 2023 | US9248229 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 May, 2023 | US9192608 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 09 Jan, 2023 | US9072781 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 02 Aug, 2019 | US9248229 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 24 May, 2019 | US9192608 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 07 Jan, 2019 | US9072781 |
| Email Notification Critical
| 12 Sep, 2016 | US9192608 |
| Filing Receipt - Corrected | 12 Sep, 2016 | US9072781 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 12 Sep, 2016 | US9192608 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 12 Sep, 2016 | US9072781 |
Morphine Sulfate's Family Patents
